Procter & Gamble (NYSE:PG – Free Report) had its price target lifted by DA Davidson from $159.00 to $160.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have a neutral rating on the stock. DA Davidson also issued estimates for Procter & Gamble’s Q2 2025 earnings at $1.93 EPS.
PG has been the subject of a number of other reports. JPMorgan Chase & Co. upped their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Piper Sandler initiated coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Finally, Royal Bank of Canada boosted their price target on shares of Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $177.00.
Check Out Our Latest Stock Report on PG
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 EPS. The firm’s revenue was down .6% on a year-over-year basis. As a group, equities research analysts predict that Procter & Gamble will post 6.94 EPS for the current year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is presently 69.48%.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 385,186 shares of company stock valued at $65,479,358 over the last three months. Corporate insiders own 0.18% of the company’s stock.
Institutional Trading of Procter & Gamble
A number of institutional investors have recently modified their holdings of the business. Legal & General Group Plc lifted its stake in shares of Procter & Gamble by 0.6% during the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after buying an additional 122,190 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Procter & Gamble by 8.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock valued at $1,598,510,000 after buying an additional 733,440 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Procter & Gamble by 9.7% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 6,161,507 shares of the company’s stock worth $999,705,000 after purchasing an additional 545,601 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Procter & Gamble by 1.3% in the 1st quarter. Janus Henderson Group PLC now owns 6,008,938 shares of the company’s stock worth $974,914,000 after purchasing an additional 79,665 shares in the last quarter. Finally, Canada Pension Plan Investment Board lifted its stake in Procter & Gamble by 3.9% in the 2nd quarter. Canada Pension Plan Investment Board now owns 5,706,199 shares of the company’s stock worth $941,066,000 after purchasing an additional 216,300 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- The How and Why of Investing in Gold Stocks
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- 3 Tickers Leading a Meme Stock Revival
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.